Killer carriers for malignant cells
Nature Materials
April 18, 2011
A drug-delivery nanocarrier with high capacity that specifically targets human liver carcinoma cells is reported online in Nature Materials this week. The highly efficient carriers have the potential to significantly increase the effectiveness of conventional chemotherapy and decrease its side effects. The carriers synthesized by Carlee Ashley, C. Jeffrey Brinker and colleagues are porous silica nanoparticles wrapped with a lipid membrane that is functionalized with targeting peptides, fusogenic peptides and the polymer polyethylene glycol. The team reports that polyethylene glycol enhances the carrier’s stability whereas the peptides give the nanoparticles high binding affinity to malignant cells. The peptides also induce the cancer cells to engulf the nanoparticles, allowing them to release their cargo in the cytosol. Compared with liposomes, the hybrid nanocarriers improve on capacity, selectivity and stability. “The nanocarriers are so potent that on average a single particle is sufficient to kill a model hepatic carcinoma cell”, says Darrell Irvine in an accompanying News & Views.
doi: 10.1038/nmat2992
Research highlights
-
Jul 1
Space health: The path of most resistance could help limit bone loss during spaceflightScientific Reports
-
Jun 30
Evolution: Hawks learn on the fly to swoop up before perchingNature
-
Jun 28
Astronomy: Hydrogen- and helium-rich exoplanets may provide habitable conditions for billions of yearsNature Astronomy
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 22
Planetary science: Modelling electrolyte transport in water-rich exoplanetsNature Communications